ClinicalTrials.Veeva

Menu

Comparison of Non-Surgical Treatment Options for Chronic Exertional Compartment Syndrome (CECS)

Walter Reed National Military Medical Center logo

Walter Reed National Military Medical Center

Status and phase

Completed
Phase 2

Conditions

Chronic Exertional Compartment Syndrome

Treatments

Drug: Botulinum Toxin Injection
Behavioral: Supervised Gait Retraining
Drug: Saline Injection
Behavioral: Home Based Gait Retraining

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT04409600
WRNMMC-2019-0266

Details and patient eligibility

About

Chronic Exertional Compartment Syndrome (CECS) in the lower leg is a debilitating condition in highly active individuals. Pain occurs in 1 or several leg compartments upon an exertional activity, typically running, that quickly dissipates once the activity stopped. Surgical fasciotomy is the standard for treating lower leg CECS, but success is variable. Complications may occur post-surgery and there is a potential for a repeat procedure. Recovery times post-surgery also vary greatly. Conservative treatments, such as gait retraining and botulinum toxin injections, are emerging as non-surgical options for the treatment of CECS with success through published case reports and case series. This study aims to evaluate the use of these non-surgical treatment options for CECS in the anterior and lateral leg compartments with a follow up for at least 2 years across multiple study sites.

Enrollment

46 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Active duty service
  • Fluent in speaking and reading English
  • Unable to run 2 miles without producing pain and/or symptoms
  • Difficulty completing the running portion of their service-specific physical training due to pain and/or symptoms in their lower leg
  • Meets clinical diagnostic criteria for CECS of the anterior or lateral compartment per clinical examination (palpation, intramuscular compartment pressure, lower leg MRI).

Exclusion criteria

  • Prior botulinum injection in the lower leg compartment of the affected limb
  • Prior compartment release of affected lower leg
  • Recent (within the last 6 months) lower limb injury that needed medical intervention
  • Completed formal gait retraining within the last 6 months
  • Allergic to botulinum toxin
  • Pregnant or breastfeeding
  • Medical examination that indicates a condition other than CECS

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

46 participants in 4 patient groups

Home Based Gait Retraining + Saline Injection
Active Comparator group
Treatment:
Behavioral: Home Based Gait Retraining
Drug: Saline Injection
Home Based Gait Retraining + Botulinum Toxin Injection
Experimental group
Treatment:
Behavioral: Home Based Gait Retraining
Drug: Botulinum Toxin Injection
Supervised Gait Retraining + Saline Injection
Active Comparator group
Treatment:
Drug: Saline Injection
Behavioral: Supervised Gait Retraining
Supervised Gait Retraining + Botulinum Toxin Injection
Experimental group
Treatment:
Behavioral: Supervised Gait Retraining
Drug: Botulinum Toxin Injection

Trial documents
1

Trial contacts and locations

4

Loading...

Central trial contact

Teonette Velasco, DPT; Jeffrey Leggit, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems